PDK1 and prostate cancer: Mechanistic studies demonstrate that the overexpression of hsa‐miR‐3916 significantly downregulates the protein expression of pyruvate dehydrogenase kinase 1 (PDK1), thereby attenuating glycolytic metabolism and suppressing the migratory and invasive capacities of prostate cancer (PCa) cells.